Page 6 - Healthcare Sector

Fortis plans to add 700 beds in FY25: MD & CEO Ashutosh Raghuvanshi

Raghuvanshi provides an overview of the company's FY24 performance and expansion plans for FY25

Healthcare sector most violative of advertisement rules, says Asci report

For the first time, the baby care sector has made it to the list of top 10 violators owing to influencers promoting products and services without disclosing material connections

Looking to add around 1,000 beds by early FY26: Max Healthcare CMD Soi

Soi gives an overview of the company's performance in FY24 and its expansion plans for FY25

KKR acquires minority stake in Healthcare BPO firm Infinx for Rs 1,250 cr

Founded in 2012, Infinx is a provider of innovative, data-driven revenue cycle management solutions for the healthcare sector, with a particular focus on the US market

BHU study on Covaxin side effects poorly designed: ICMR director Bahl

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" ICMR. Dr Bahl said the study had no control arm of unvaccinated individuals for comparing the rates of events between the vaccinated and unvaccinated groups. Hence, the reported events in the study cannot be linked or attributed to COVID-19 vaccination. The ICMR is not associated with the study and has not provided any financial or technical support for the research, Dr Bahl said. The ICMR DG has written a letter to the authors of the paper and Editor of the journal to immediately remove the acknowledgement to ICMR and publish an erratum. A research paper, titled 'Long-Term Safety Analysis of the BBVl52 Coronavirus Vaccine in Adolescents and Adults: Findings from a l-Year Prospective Stud

Hospital players enhance focus on cancer care amid a surge in cases

By 2025, cancer cases projected to hit 1.57 million, up 13% from 2020

Indian GenAI platform Hanooman goes live in 98 global languages

The platform is presently accessible for free, and the premium subscription plan will be launched later this year, said the company

11 accused sent to CBI remand for bribery racket in Delhi's RML Hospital

The CBI arrested Channappagouda and RML cardiology Professor Ajay Raj for taking bribes from medical equipment suppliers to use their products and stents

Lupin appoints Jeffrey Kindler, Alfonso 'Chito' Zulueta as independent dirs

Pharma major Lupin Ltd on Thursday announced appointments of ex-Pfizer Chairman and CEO, Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors on its board. Kindler is currently the CEO of Centrexion Therapeutics, a privately-held biotechnology company, Senior Advisor to Blackstone, Operating Partner at ARTIS Ventures and Global Chair of GLG Institute, Lupin said in a regulatory filing. He brings over four decades of business experience holding leadership positions at some of the world's most recognised companies, including Pfizer, where he served as Chairman & Chief Executive Officer, as well as McDonald's Corporation and General Electric Company, the company added. Before that, he was a partner at law firm Williams & Connolly. Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Ltd, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia, Lupin said. He is also President ..

Quadria Capital picks up minority stake in NephroPlus for Rs 850 crore

Founded in 2010, NephroPlus currently operates about 450 dialysis centres across three main countries: India, the Philippines, and Uzbekistan

Abbott launches XIENCE Sierra coronary stent system for heart patients

The XIENCE Sierra is the latest generation of the XIENCE family of everolimus-eluting coronary stent systems

Healthcare industry announces support for talks on standardising rates

Many industry bodies too had become party to the case, urging the apex court to listen to their grievances as well

Manipal Hospitals to take 87% stake in Medica Synergie for Rs 1.4K crore

The acquisition comes as the hospital chain has been working towards expansion efforts. In September 2023, Manipal Hospitals had acquired an 84 per cent stake in Emami Group's AMRI Hospitals

Indegene sets IPO price band at Rs 430-452, aims to raise Rs 1,842 crore

In financial year 2023, Indegene reported Rs 2,306.13 crore in revenue from operations with a profit of Rs 266 crore

Apollo Hospitals lines up Rs 3,000 crore investment post Advent deal

Advent and Apollo HealthCo have entered into a deal through which Advent will invest Rs 2,475 crore into Apollo HealthCo

Dr Basu Eye Hospital plans to open five new hospitals in India in 5 years

The hospital claims that the costs of their treatments are significantly lower compared to traditional surgeries and modern medical treatments

India's role in medical product space represents unique opportunity: FDA

The role of India in the medical product field represents both a unique opportunity and an important responsibility, the head of the US Food and Drug Administration has said, ahead of the annual India-US BioPharma & Healthcare Summit. The summit will take place in Boston later this week. Dr Robert Califf, US FDA Commissioner will be one of the keynote speakers at the 18th edition of the annual largest gathering of pharma and healthcare sectors from the two countries, organised by USA India Chamber of Commerce. During the day-long summit, Dr Califf will share insights from his significant visit to India last September, which holds paramount importance for both countries, USA India Chamber of Commerce said in a statement on Sunday. I recently visited India with a central purpose in mindto strengthen our collective efforts to advance the development and availability of medical products that both our countries and the rest of the world need, he said. I knew, going into my trip, that .

Cipla Health signs agreement, strengthens beauty play with Ivia's brands

Cipla Health strengthens beauty play in Tier II-VI towns with Ivia Beaute's cosmetics, personal care distribution and marketing biz

Healthcare solution provider Enhanced Innovations launches 'Phloton'

A portable cold chain solution for last-mile vaccine delivery

Valuations hurdle likely to keep GSK Pharma stock under pressure

Even as the top pharmaceutical peers delivered a double digit growth in the December quarter, sales for GSK Pharma at Rs 805 crore was flat